-
公开(公告)号:US5023568A
公开(公告)日:1991-06-11
申请号:US540017
申请日:1990-06-18
CPC分类号: H03F1/48 , H03F3/3432 , H03F3/45071 , H03F3/45479
摘要: A combined current difference and operational amplifier circuit (10) for use either as or in a filter embodied in an integrated receiver includes inputs (I.sub.A and I.sub.B) for oppositely phased current signals which are applied to a current mirror circuit formed by first and second NPN transistors (Q1,Q2) having their bases connected to a junction (20). Equal value resistors (R1,R2) are serially connected in the emitter circuits of the first and second transistors, respectively and the current inputs are coupled to the free ends of the resistors. The base-collector path of a third NPN transistor (Q3) is connected between the free end of one of the resistors (R1) and the junction (20). A current difference signal (i.sub.b -i.sub.a) derived from the free end of the other one of the resistors is applied to the virtual ground input of an operational amplifier formed by a common emitter stage (Q4) coupled to an emitter follower (Q5). The operational amplifier has a capacitive (C1) feedback between its output and virtual ground input so that the d.c. potential at said input has no effect on the d.c. operating point of the output.As an alternative, resistive (Rf) feedback may be used instead of the capacitive feedback.Another embodiment (FIG. 2) enables the input and output voltage swings to be increased without unduly degrading the bandwidth.
摘要翻译: 用于集成接收机中实现的或在滤波器中使用的组合电流差和运算放大器电路(10)包括用于相反相位电流信号的输入(IA和IB),其被施加到由第一和第二NPN形成的电流镜电路 其基极连接到结(20)的晶体管(Q1,Q2)。 等电阻电阻(R1,R2)分别串联连接在第一和第二晶体管的发射极电路中,电流输入耦合到电阻器的自由端。 第三NPN晶体管(Q3)的基极 - 集电极路径连接在电阻器(R1)中的一个的自由端和结(20)之间。 从另一个电阻器的自由端导出的电流差信号(ib-ia)被施加到由耦合到射极跟随器(Q5)的公共发射极级(Q4)形成的运算放大器的虚拟接地输入。 运算放大器在其输出和虚拟接地输入之间具有电容(C1)反馈,使得直流 所述输入的电位对直流电压没有影响。 输出的工作点。 作为替代,可以使用电阻(Rf)反馈来代替电容反馈。 另一实施例(图2)能够增加输入和输出电压摆幅,而不会过度地降低带宽。
-
公开(公告)号:US4779056A
公开(公告)日:1988-10-18
申请号:US128666
申请日:1987-12-04
申请人: Paul A. Moore , Colin L. Perry
发明人: Paul A. Moore , Colin L. Perry
CPC分类号: H03H19/004 , H03H11/126
摘要: A filter comprises an amplifier circuit arrangement having a signal input (1) and a signal output (8) and a coupling (36) between a point (37) on a signal path (39) to the signal input and a point (38) on a signal path from the signal output. The amplifier circuit arrangement comprises an inverting amplifier (6) to the input (5) of which the signal input (1) is connected via a series impedance (7), e.g. a resistor. A feedback impedance (9), e.g. a capacitor, connects the amplifier output (8) to its input so that this input constitutes a virtual ground. The phase relationship between the input and output signals of such an arrangement changes from inverting to non-inverting at frequencies at which the gain of the amplifier drops to below unity because of forward feed through the feedback impedance (9), thereby upsetting the phase relationship between the signals passing through the arrangement and those passing through the coupling. Accordingly, a further impedance (10), e.g. a capacitance, is provided between the common point ( 11) of the series and feedback impedances and ground. At frequencies at which the amplifier gain is high, this further impedance has virtually no effect because of the virtual ground existing at the common point (11). However, at frequencies at which the amplifier gain drops to unity or below, the virtual ground effect is lost and the further impedance forms a potential divider with the series impedance (7), reducing the proportion of the input signal which can take the direct forward path through the feedback impedance.
摘要翻译: 滤波器包括具有信号输入(1)和信号输出(8)的放大器电路装置以及信号路径(39)上与信号输入端之间的点(37)和点(38)之间的耦合(36) 在信号输出的信号路径上。 放大器电路装置包括到输入端(5)的反相放大器(6),其中信号输入端(1)经由串联阻抗(7)连接。 一个电阻 反馈阻抗(9),例如 电容器将放大器输出(8)连接到其输入端,使得该输入构成虚拟接地。 这种布置的输入和输出信号之间的相位关系由于通过反馈阻抗(9)的正向馈送而在放大器的增益下降到低于单位的频率处从反相变为非反相,从而使相位关系 通过布置的信号和通过耦合的那些信号。 因此,另外的阻抗(10),例如 在串联的公共点(11)和反馈阻抗和接地之间提供电容。 在放大器增益高的频率处,由于在公共点处存在虚拟地线(11),所以这个进一步的阻抗几乎没有任何影响。 然而,在放大器增益下降到一个或更低的频率下,虚拟接地效应就会消失,另外的阻抗与串联阻抗(7)形成一个分压器,从而减少可以直接向前的输入信号的比例 路径通过反馈阻抗。
-
公开(公告)号:US08802091B2
公开(公告)日:2014-08-12
申请号:US13463924
申请日:2012-05-04
申请人: Leslie S. Johnson , Ling Huang , Paul A. Moore , Deryk T. Loo , Francine Z. Chen
发明人: Leslie S. Johnson , Ling Huang , Paul A. Moore , Deryk T. Loo , Francine Z. Chen
IPC分类号: A61K38/00
CPC分类号: C07K16/2827 , A61K39/39558 , A61K45/06 , A61K47/6849 , A61K47/6851 , A61K47/6855 , A61K2039/505 , C07K16/2809 , C07K16/30 , C07K16/3023 , C07K16/3046 , C07K16/3069 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/622 , C07K2317/626 , C07K2317/73 , C07K2317/76 , C07K2317/77 , C07K2317/94 , G01N33/57484 , A61K2300/00
摘要: The present invention relates to antibodies that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.
摘要翻译: 本发明涉及对哺乳动物,特别是人B7-H3受体及其用途,特别是治疗癌症和炎症的免疫反应性的抗体。 因此,本发明特别涉及能够介导,更优选增强针对与多种人类癌症相关的癌细胞的免疫系统的活化的人源化B7-H3-反应性抗体。
-
公开(公告)号:US08143026B2
公开(公告)日:2012-03-27
申请号:US12534585
申请日:2009-08-03
申请人: Craig A. Rosen , William A. Haseltine , Steven M. Ruben , Paul A. Moore , Jason B. Bock , David LaFleur
发明人: Craig A. Rosen , William A. Haseltine , Steven M. Ruben , Paul A. Moore , Jason B. Bock , David LaFleur
CPC分类号: C07K14/765 , A61K38/00 , C07K2319/31 , C07K2319/35 , C12N15/62
摘要: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
摘要翻译: 本发明包括白蛋白融合蛋白。 编码本发明的白蛋白融合蛋白的核酸分子也包括在本发明中,载体含有这些核酸,用这些核酸载体转化的宿主细胞,以及制备本发明的白蛋白融合蛋白并使用这些核酸的方法 酸,载体和/或宿主细胞。 另外,本发明包括包含白蛋白融合蛋白的药物组合物以及使用本发明的白蛋白融合蛋白来治疗,预防或改善疾病,病症或病症的方法。
-
公开(公告)号:US20090305991A1
公开(公告)日:2009-12-10
申请号:US12538668
申请日:2009-08-10
申请人: Daniel R. Soppet , Paul A. Moore , Yanggu Shi , Steven M. Ruben , Craig A. Rosen , David W. LaFleur , Henrik Olsen , Reinhard Ebner , Kimberly Florence , Paul Young , George Komatsoulis , Jian Ni
发明人: Daniel R. Soppet , Paul A. Moore , Yanggu Shi , Steven M. Ruben , Craig A. Rosen , David W. LaFleur , Henrik Olsen , Reinhard Ebner , Kimberly Florence , Paul Young , George Komatsoulis , Jian Ni
IPC分类号: A61K38/16 , C12N15/11 , C12N15/00 , C12N15/87 , C12N5/06 , C12N1/21 , C07K14/435 , C07K16/18 , C12P21/02 , C12Q1/68 , C12Q1/02 , G01N33/566
摘要: The present invention relates to 33 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
摘要翻译: 本发明涉及33种新型人分泌蛋白和含有编码这种蛋白质的基因的编码区的分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。
-
公开(公告)号:US20090088555A1
公开(公告)日:2009-04-02
申请号:US12274626
申请日:2008-11-20
申请人: David W. LaFleur , Steven M. Ruben , Craig A. Rosen , Paul A. Moore , Yanggu Shi , Hla Kyaw , Ying-Fei Wei
发明人: David W. LaFleur , Steven M. Ruben , Craig A. Rosen , Paul A. Moore , Yanggu Shi , Hla Kyaw , Ying-Fei Wei
CPC分类号: C12Q1/6883 , A61K35/13 , A61K38/00 , C07K14/47 , G01N33/6893 , Y02A50/465
摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.
摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的病症的诊断和治疗方法。
-
公开(公告)号:US20080194481A1
公开(公告)日:2008-08-14
申请号:US11932823
申请日:2007-10-31
申请人: Craig A. Rosen , Adam Bell , Paul A. Moore , Yanggu Shi , David LaFleur , Jason B. Bock , Michael W. Laird , William A. Haseltine , Douglas B. Woods , Mani Subramanian
发明人: Craig A. Rosen , Adam Bell , Paul A. Moore , Yanggu Shi , David LaFleur , Jason B. Bock , Michael W. Laird , William A. Haseltine , Douglas B. Woods , Mani Subramanian
IPC分类号: A61K38/00 , C07K14/00 , C12N15/11 , C12N15/00 , C12N5/06 , A61P9/00 , A61P1/00 , A61P25/00 , C12N1/00 , C12N1/20 , C12P21/04
CPC分类号: C07K14/58 , C07K14/765 , C07K2319/01
摘要: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
-
公开(公告)号:US06903072B2
公开(公告)日:2005-06-07
申请号:US09345373
申请日:1999-07-01
申请人: Steven M. Ruben , Pablo Jimenez , D. Roxanne Duan , Mark A. Rampy , Donna Mendrick , Jun Zhang , Jian Ni , Paul A. Moore , Timothy A. Coleman , Joachim R. Gruber , Patrick J. Dillon , Reiner L. Gentz
发明人: Steven M. Ruben , Pablo Jimenez , D. Roxanne Duan , Mark A. Rampy , Donna Mendrick , Jun Zhang , Jian Ni , Paul A. Moore , Timothy A. Coleman , Joachim R. Gruber , Patrick J. Dillon , Reiner L. Gentz
CPC分类号: C07H21/00 , A61K38/00 , A61K48/00 , C07K14/50 , C12N2799/026 , Y10S514/925
摘要: This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as “KGF-2” also formerly known as Fibroblast Growth Factor 12 (FGF-12). This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, increased stability, higher yield or better solubility.
-
公开(公告)号:US06605592B2
公开(公告)日:2003-08-12
申请号:US09800729
申请日:2001-03-08
申请人: Jian Ni , Kevin P. Baker , Charles E. Birse , Reinhard Ebner , Michele Fiscella , George A. Komatsoulis , David W. LaFleur , Paul A. Moore , Henrik S. Olsen , Craig A. Rosen , Steven M. Ruben , Daniel R. Soppet , Paul E. Young , Ping Wei , Kimberly A. Florence
发明人: Jian Ni , Kevin P. Baker , Charles E. Birse , Reinhard Ebner , Michele Fiscella , George A. Komatsoulis , David W. LaFleur , Paul A. Moore , Henrik S. Olsen , Craig A. Rosen , Steven M. Ruben , Daniel R. Soppet , Paul E. Young , Ping Wei , Kimberly A. Florence
IPC分类号: C07K1447
CPC分类号: C07K14/47
摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. In particular, the present application relates to a novel human protein, Protein HOFNF53. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 特别地,本申请涉及新的人蛋白质蛋白质HOFNF53。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。
-
公开(公告)号:US06475753B1
公开(公告)日:2002-11-05
申请号:US09461325
申请日:1999-12-14
申请人: Steven M. Ruben , Jian Ni , Craig A. Rosen , Ying-Fei Wei , Paul Young , Kimberly Florence , Daniel R. Soppet , Laurie A. Brewer , Gregory A. Endress , Kenneth C. Carter , Michael Mucenski , Reinhard Ebner , David W. Lafleur , Henrik Olsen , Yanggu Shi , Paul A. Moore , George Komatsoulis
发明人: Steven M. Ruben , Jian Ni , Craig A. Rosen , Ying-Fei Wei , Paul Young , Kimberly Florence , Daniel R. Soppet , Laurie A. Brewer , Gregory A. Endress , Kenneth C. Carter , Michael Mucenski , Reinhard Ebner , David W. Lafleur , Henrik Olsen , Yanggu Shi , Paul A. Moore , George Komatsoulis
IPC分类号: C12P2102
CPC分类号: G01N33/6893 , A61K38/00 , C07K14/47 , G01N2500/20
摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.
摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的病症的诊断和治疗方法。
-
-
-
-
-
-
-
-
-